The Management of Cellulitis and Erysipelas at an Academic

Total Page:16

File Type:pdf, Size:1020Kb

The Management of Cellulitis and Erysipelas at an Academic Emergency Care Journal 2017; volume 13:6343 The management of cellulitis and erysipelas at an academic Introduction Correspondence: Jeff Martin, Department of Visits for cellulitis and erysipelas repre- Family Medicine, Queen’s University, emergency department: current Kingston, 76 Stuart St, Kingston, ON K7L sent a large proportion of cases seen by practice versus the literature 2V7, Canada. emergency physicians. Basic emergency Tel: +613-548-3232. department management consists of antibi- E-mail: [email protected] Jeffrey W. Martin,1 Ruth Wilson,1 otics and appropriate supportive care, deter- Tim Chaplin2 mining if an admission to hospital is neces- Key words: Cellulitis, Antibiotics, Emergency medicine. 1Department of Family Medicine, Queen’s sary, and arranging appropriate follow-up. Antibiotic therapy targeted against beta- University, Kingston, Ontario; Acknowledgements: we thank David Barber hemolytic streptococci and Staphylococcus 2Department of Emergency Medicine, for assisting with electronic medical record aureus, methicillin-sensitive or methicillin- data collection. Queen’s University, Kingston, Ontario, resistant, is the mainstay of treatment for 1 Canada children and adults with these infections. Contributions: JWM contributed to study con- However, overall severity of illness and cept and design, acquisition of the data, analy- underlying comorbidities ultimately deter- sis and interpretation of the data, drafting of mine variables such as delivery route, the manuscript, and critical revision of the dosage, frequency, and class of agent.2 manuscript for important intellectual content. Abstract CRW and TC contributed to study concept and Cephalexin, a first generation design, critical revision of the manuscript for Cellulitis and erysipelas are common cephalosporin, is the preferred oral antibiot- important intellectual content, and study presentations to emergency departments ic for uncomplicated cellulitis without supervision. and family physicians. Evidence-based abscess.3 Published indications for parenter- guidelines for appropriate management of al antibiotics in cellulitis include compro- Conflicts of interest: the authors declare no these infections exist in Canada, but incon- mised oral administration, immunocompro- potential conflict of interest. sistent practices persist. Our objective was mise, and signs of systemic infection.2 Conference presentation: a poster based on These guidelines are incorporated into rec- to determine the level of adherence to cur- this manuscript was accepted for presentation rent evidence and guidelines by emergency ommendations for providers across 4-6 at the Canadian Association of Emergency physicians at the two hospitals in Kingston, Canada. Outpatient parenteral antibiotic Physicians (CAEP) Conference 2017. Ontario, Canada. We identified all of the therapy (OPAT) is chosen for some patients, electronic medical records of patients who and has several advantages, namely as a Received for publication: 11 October 2016. cost-saving measure for the healthcare sys- Revision received: 24 May 2017. were seen at Kingston General Hospital or Accepted for publication: 25 May 2017. Hotel Dieu Hospital between January 1, tem, because patients avoid admission to hospital and repeat visits to the emergency 2015 and June 30, 2015 and given a diagno- This work is licensed under a Creative department.7 In this study, we describe the sis of cellulitis or erysipelas. We randomly Commons Attribution 4.0 License (by-nc 4.0). management practices of emergency physi- selected 182 charts and conducted a retro- cians in Kingston, Ontario for patients diag- ©Copyright J.W. Martin et al., 2017 spective chart review, manually collecting nosed with cellulitis or erysipelas. Licensee PAGEPress, Italy data for patient demographics, medical his- Emergency Care Journal 2017; 13:6343 tory, and medical management. Oral doi:10.4081/ecj.2017.6343 cephalexin alone was given to 44% of our sample, and it was the most common form Materials and Methods of therapy for uncomplicated cellulitis. 36% domly selected a subset of these charts for of patients given any antibiotics at all Study design and population data collection, but excluded charts if they received at least one dose of parenteral We conducted a retrospective chart were inaccessible or did not contain usable antibiotics, despite only 6.7% of these review at Kingston General Hospital data, patients were not seen by an emergen- patients showing systemic signs of illness. (KGH) and Hotel Dieu Hospital (HDH) in cy physician, patients were younger than 1 88% of those receiving parenteral antibi- Kingston, Ontario, Canada. KGH is a ter- year old, or there was a suspected diagnosis tiary care centre and HDH is an ambulatory otics received ceftriaxone, a broad-spec- of preseptal or orbital cellulitis. urgent care centre. They are both teaching trum, third generation cephalosporin. We Patient data were manually collected for hospitals and serve about 500,000 residents found wide variation in antibiotic selection vital signs at time of triage, and patient fac- in southeastern Ontario. A team of emergen- and route of administration for patients pre- tors or comorbidities that may increase the cy physicians staff both the KGH emergen- senting to the emergency department with risk of complications of cellulitis and cy department and the HDH urgent care cellulitis or erysipelas. Overuse of antibi- erysipelas or may predispose to communi- centre and see approximately 100,000 otics is common, and we believe the use of ty-acquired MRSA infection. The comor- patients per year. Ethics approval was parenteral antibiotics may have been unnec- bidities and patient factors we included obtained from the Queen’s University essary for some patients in our sample. Health Sciences Research Ethics Board. were known diabetes, active cancer treat- Emergency physicians should align their ment, documented cancer diagnosis within management plans more closely with the Data collection 6 months, history of organ transplant, intra- current guidelines to improve practice and We identified all of the charts from the venous drug use, or residence in an assisted reduce unnecessary administration of electronic medical record (EMR) for the 6- living environment or shelter. We deter- broad-spectrum parenteral antibiotics. month period between January 1, 2015 and mined whether antibiotics were given; the June 30, 2015 for patients with a discharge dose and route of the antibiotics (parenteral, diagnosis of cellulitis or erysipelas. We ran- topical, oral); whether they were admitted [page 28] [Emergency Care Journal 2017; 13:6343] Article or discharged home with follow up; dura- tions thereof (n=5). Three patients were prim/sulfamethoxazole, and metronidazole tion and length of time until route switch, noted to be discharged with oral antibiotics, were used alone or in combination with a where applicable; as well as any explicit but no specific details were available. cephalosporin in 22% (12 of 55) of cases, reasoning behind the choice of treatment. Thirteen of those given only oral antibiotics but explicit reasoning was not recorded in We also tracked who returned to the emer- returned to the emergency department for a most of the charts (Figure 2). gency department within two weeks of ini- scheduled recheck or to request reassess- Emergency physicians used a variety of tial presentation for worsening disease, ment. Six of these patients continued their antibiotic classes, combinations, and routes adverse events related to treatment; and existing course of management, but six oth- of administration (Table 2). Four patients whether there were any complications relat- ers received parenteral antibiotics, and one were noted to have allergies to penicillin or ed to treatment, such as allergic reactions. patient started ciprofloxacin and metronida- cephalexin, but clinical reasoning for antibi- zole but was eventually admitted after fur- otic choice and acknowledgment of the Data analysis ther return visits. presence of allergies was otherwise absent Data were analysed using descriptive Greater than one third of the patients in the documentation. statistics. Data abstraction and analysis given any antibiotics at their first visit (60 There were 62 return visits to the were done using Microsoft Excel. of 166) received empiric parenteral therapy emergency department within 2 weeks of for cellulitis, then were switched to or aug- discharge from emergency. This number mented with oral antibiotics if improvement included 46 who returned for scheduled was observed. 88% (53 of 60) received cef- rechecks, repeat doses of IV antibiotics; or Results triaxone, some augmented with van- addition of IV antibiotics to the manage- comycin (n=3) or metronidazole (n=2), and ment plan, due to worsening infection Patients’ characteristics the remaining patients received cefazolin There were 707 visits to KGH and HDH (n=5 [one patient received both ceftriaxone (n=3). Nine patients were admitted upon for cellulitis or erysipelas between January and cefazolin]), clindamycin (n=1), cef- returning for rechecks. Of the remaining 2015 and June 2015. We randomly selected tazidime (n=1), or an unknown parenteral visits, one patient returned with anaphy- 182 of these charts for study, 178 of which antibiotic (n=1) (Figure 1). One patient laxis, possibly secondary to the cephalexin were for patients diagnosed with cellulitis given parenteral antibiotics during their ini- or doxycycline prescribed; a second
Recommended publications
  • Naeglaria and Brain Infections
    Can bacteria shrink tumors? Cancer Therapy: The Microbial Approach n this age of advanced injected live Streptococcus medical science and into cancer patients but after I technology, we still the recipients unfortunately continue to hunt for died from subsequent innovative cancer therapies infections, Coley decided to that prove effective and safe. use heat killed bacteria. He Treatments that successfully made a mixture of two heat- eradicate tumors while at the killed bacterial species, By Alan Barajas same time cause as little Streptococcus pyogenes and damage as possible to normal Serratia marcescens. This Alani Barajas is a Research and tissue are the ultimate goal, concoction was termed Development Technician at Hardy but are also not easy to find. “Coley’s toxins.” Bacteria Diagnostics. She earned her bachelor's degree in Microbiology at were either injected into Cal Poly, San Luis Obispo. The use of microorganisms in tumors or into the cancer therapy is not a new bloodstream. During her studies at Cal Poly, much idea but it is currently a of her time was spent as part of the undergraduate research team for the buzzing topic in cancer Cal Poly Dairy Products Technology therapy research. Center studying spore-forming bacteria in dairy products. In the late 1800s, German Currently she is working on new physicians W. Busch and F. chromogenic media formulations for Fehleisen both individually Hardy Diagnostics, both in the observed that certain cancers prepared and powdered forms. began to regress when patients acquired accidental erysipelas (cellulitis) caused by Streptococcus pyogenes. William Coley was the first to use New York surgeon William bacterial injections to treat cancer www.HardyDiagnostics.com patients.
    [Show full text]
  • Diagnostic Code Descriptions (ICD9)
    INFECTIONS AND PARASITIC DISEASES INTESTINAL AND INFECTIOUS DISEASES (001 – 009.3) 001 CHOLERA 001.0 DUE TO VIBRIO CHOLERAE 001.1 DUE TO VIBRIO CHOLERAE EL TOR 001.9 UNSPECIFIED 002 TYPHOID AND PARATYPHOID FEVERS 002.0 TYPHOID FEVER 002.1 PARATYPHOID FEVER 'A' 002.2 PARATYPHOID FEVER 'B' 002.3 PARATYPHOID FEVER 'C' 002.9 PARATYPHOID FEVER, UNSPECIFIED 003 OTHER SALMONELLA INFECTIONS 003.0 SALMONELLA GASTROENTERITIS 003.1 SALMONELLA SEPTICAEMIA 003.2 LOCALIZED SALMONELLA INFECTIONS 003.8 OTHER 003.9 UNSPECIFIED 004 SHIGELLOSIS 004.0 SHIGELLA DYSENTERIAE 004.1 SHIGELLA FLEXNERI 004.2 SHIGELLA BOYDII 004.3 SHIGELLA SONNEI 004.8 OTHER 004.9 UNSPECIFIED 005 OTHER FOOD POISONING (BACTERIAL) 005.0 STAPHYLOCOCCAL FOOD POISONING 005.1 BOTULISM 005.2 FOOD POISONING DUE TO CLOSTRIDIUM PERFRINGENS (CL.WELCHII) 005.3 FOOD POISONING DUE TO OTHER CLOSTRIDIA 005.4 FOOD POISONING DUE TO VIBRIO PARAHAEMOLYTICUS 005.8 OTHER BACTERIAL FOOD POISONING 005.9 FOOD POISONING, UNSPECIFIED 006 AMOEBIASIS 006.0 ACUTE AMOEBIC DYSENTERY WITHOUT MENTION OF ABSCESS 006.1 CHRONIC INTESTINAL AMOEBIASIS WITHOUT MENTION OF ABSCESS 006.2 AMOEBIC NONDYSENTERIC COLITIS 006.3 AMOEBIC LIVER ABSCESS 006.4 AMOEBIC LUNG ABSCESS 006.5 AMOEBIC BRAIN ABSCESS 006.6 AMOEBIC SKIN ULCERATION 006.8 AMOEBIC INFECTION OF OTHER SITES 006.9 AMOEBIASIS, UNSPECIFIED 007 OTHER PROTOZOAL INTESTINAL DISEASES 007.0 BALANTIDIASIS 007.1 GIARDIASIS 007.2 COCCIDIOSIS 007.3 INTESTINAL TRICHOMONIASIS 007.8 OTHER PROTOZOAL INTESTINAL DISEASES 007.9 UNSPECIFIED 008 INTESTINAL INFECTIONS DUE TO OTHER ORGANISMS
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Skin and Soft Tissue Infections Ohsuerin Bonura, MD, MCR Oregon Health & Science University Objectives
    Difficult Skin and Soft tissue Infections OHSUErin Bonura, MD, MCR Oregon Health & Science University Objectives • Compare and contrast the epidemiology and clinical presentation of common skin and soft tissue diseases • State the management for skin and soft tissue infections OHSU• Differentiate true infection from infectious disease mimics of the skin Casey Casey is a 2 year old boy who presents with this rash. What is the best treatment? A. Soap and Water B. Ibuprofen, it will self OHSUresolve C. Dicloxacillin D. Mupirocin OHSUImpetigo Impetigo Epidemiology and Treatment OHSU Ellen Ellen is a 54 year old morbidly obese woman with DM, HTN and venous stasis who presented with a painful left leg and fever. She has had 3 episodes in the last 6 months. What do you recommend? A. Cefazolin followed by oral amoxicillin prophylaxis B. Vancomycin – this is likely OHSUMRSA C. Amoxicillin – this is likely erysipelas D. Clindamycin to cover staph and strep cellulitis Impetigo OHSUErysipelas Erysipelas Risk: lymphedema, stasis, obesity, paresis, DM, ETOH OHSURecurrence rate: 30% in 3 yrs Treatment: Penicillin Impetigo Erysipelas OHSUCellulitis Cellulitis • DEEPER than erysipelas • Microbiology: – 6-48hrs post op: think GAS… too early for staph (days in the making)! – Periorbital – Staph, Strep pneumoniae, GAS OHSU– Post Varicella - GAS – Skin popping – Staph + almost anything! Framework for Skin and Soft Tissue Infections (SSTIs) NONPurulent Purulent Necrotizing/Cellulitis/Erysipelas Furuncle/Carbuncle/Abscess Severe Moderate Mild Severe Moderate Mild I&D I&D I&D I&D IV Rx Oral Rx C&S C&S C&S C&S Vanc + Pip-tazo OHSUEmpiric IV Empiric MRSA Oral MRSA TMP/SMX Doxy What Are Your “Go-To” Oral Options For Non-Purulent SSTI? Amoxicillin Doxycycline OHSUCephalexin Doxycycline Trimethoprim-Sulfamethoxazole OHSU Miller LG, et al.
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]
  • Listeriosis (“Circling Disease”) Extended Version
    Zuku Review FlashNotesTM Listeriosis (“circling disease”) Extended Version Classic case: Silage-fed adult cow, head tilt, circling, asymmetric sensation loss on face Presentation: Signalment and History Adult cattle, sheep, goats, (possibly camelids) . Indoors in winter with feeding of silage . Extremely rare in horses Poultry and pet birds Human listeria outbreaks Clinical signs (mammals) Head tilt Circling Dullness Sensory and motor dysfunction of trigeminal nerve . Asymmetric sensory loss on face . Weak jaw closure Purulent ophthalmitis Exposure keratitis Isolation from rest of herd Ocular and nasal discharge Listeriosis in a Holstein. Food remaining in mouth Note the head tilt and drooped ear Bloat Marked somnolence Tetraparesis, ataxia Poor to absent palpebral reflexes Difficulty swallowing/poor gag reflex Tongue paresis Obtundation, semicoma, death Clinical signs (avian listeriosis) Often subclinical Older birds and poultry (septicemia) . Depression, lethargy . Sudden death Younger birds and poultry (chronic form) . Torticollis . Paresis/paralysis DDX: Listeriosis in an ataxic goat Mammals Brainstem abscess, basilar empyema, otitis media/interna, Maedi-Visna, rabies, caprine arthritis-encephalitis, Parelaphostrongylus tenuis, scrapie Avian Colibacillosis, pasteurellosis, erysipelas, velogenic viscerotropic Newcastle disease 1 Zuku Review FlashNotesTM Listeriosis (“circling disease”) Extended Version Test(s) of choice: Mammals-Clinical signs and Cerebrospinal fluid (CSF) analysis . Mononuclear pleocytosis,
    [Show full text]
  • “Candidatus Neoehrlichia Mikurensis” Mimic Noninfectious Conditions in Patients with B Cell Malignancies Or Autoimmune Diseases
    MAJOR ARTICLE Infections With the Tick-Borne Bacterium “Candidatus Neoehrlichia mikurensis” Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases Anna Grankvist,1 Per-Ola Andersson,2 Mattias Mattsson,3 Monica Sender,2 Krista Vaht,2 Linnea Höper,4 Egidija Sakiniene,4 Estelle Trysberg,4 Martin Stenson,5 Jan Fehr,6 Sona Pekova,7 Christian Bogdan,8 Guido Bloemberg,9 and Christine Wennerås1,2 1Department of Clinical Microbiology/Infectious Diseases, Sahlgrenska Academy, Sahlgrenska University Hospital, Göteborg; 2Department of Hematology Downloaded from and Coagulation, Sahlgrenska University Hospital, Göteborg; 3Department of Internal Medicine, Karlstad Hospital, Karlstad; 4Department of Rheumatology, Sahlgrenska University Hospital, Göteborg and 5Department of Medicine, Kungälv Hospital, Kungälv, Sweden; 6Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 7Laboratory for Molecular Diagnostics, CHAMBON Laboratories, Prague, Czech Republic; 8Mikrobiologische Institut—Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany and 9Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland http://cid.oxfordjournals.org/ Background. Candidatus Neoehrlichia mikurensis is a newly discovered noncultivatable bacterium spread among ticks and rodents in Europe and Asia that can infect humans, particularly immunocompromised patients.
    [Show full text]
  • Infectious Diseases of the Philippines
    INFECTIOUS DISEASES OF THE PHILIPPINES Stephen Berger, MD Infectious Diseases of the Philippines - 2013 edition Infectious Diseases of the Philippines - 2013 edition Stephen Berger, MD Copyright © 2013 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-582-4 ISBN-10: 1-61755-582-7 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content: Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application.
    [Show full text]
  • Bacterial Skin and Soft Tissue Infections
    VOLUME 39 : NUMBER 5 : OCTOBER 2016 ARTICLE Bacterial skin and soft tissue infections Vichitra Sukumaran SUMMARY Advanced trainee1 Sanjaya Senanayake Bacterial skin infections are common presentations to both general practice and the Senior specialist1 emergency department. Associate professor of 2 The optimal treatment for purulent infections such as boils and carbuncles is incision and medicine drainage. Antibiotic therapy is not usually required. 1 Infectious Diseases Most uncomplicated bacterial skin infections that require antibiotics need 5–10 days of treatment. Canberra Hospital 2 Australian National There is a high prevalence of purulent skin infections caused by community-acquired University Medical School (non‑multiresistant) methicillin-resistant Staphylococcus aureus. It is therefore important to Canberra provide adequate antimicrobial coverage for these infections in empiric antibiotic regimens. Keywords antibiotics, cellulitis, Introduction Cellulitis and erysipelas impetigo, soft tissue It is important to have a good understanding of Both cellulitis and erysipelas manifest as spreading infection the common clinical manifestations and pathogens areas of skin erythema and warmth. Localised involved in bacterial skin infections to be able to infections are often accompanied by lymphangitis and Aust Prescr 2016;39:159–63 manage them appropriately. The type of skin infection lymphadenopathy. Not infrequently, groin pain and http://dx.doi.org/10.18773/ depends on the depth and the skin compartment tenderness due to inguinal lymphadenitis will precede austprescr.2016.058 involved. The classification and management of these the cellulitis. Some patients can be quite unwell with infections are outlined in Table 1. fevers and features of systemic toxicity. Bacteraemia, although uncommon (less than 5%), still occurs. Impetigo Erysipelas involves the upper dermis and superficial Impetigo is a superficial bacterial infection that can lymphatics.
    [Show full text]
  • Detection of Causative Agents in Focus in Erysipelas Patients By
    Detection of causative agents out using the ATB Expression ( «BioMerieux») Conclusion. The primary role of the β-HSA DNA contamination of hearth of erysipelas is and test systems ID32E, ID32Staph, ID32Strep, is indisputable, in the cases with complications depends on the presence of live staphylococci in focus in erysipelas patients ID32GN, identification of β-HS in groups A, B, C, mixt-infection can take a part in the etiology of on skin surface by bacteriological method and D, F and G (at Lancefield) - a latex agglutination the disease. PCR-RT with fluorescent Staphylococci on skin: PCR reaction(Pastorex Strep Kits; «Bio-Rad»,France) hybridization detection showed the highly informative content in the study of the blood and S.aureus No staphyl. S.epid./saprop. Volchkova E.V.1, Belaia O.F.1, Troickii V.I.1, The overall frequency of detection of different Svistunova Т.S.2,Potekaeva S.N.2, microorganisms (85%) in PCR in patients bulls punctuate. and it was more informative in Staphylococcus DNA in hearth: Domonova E.A.3 with erysipelas (n=60) identifying the microflora in patients with 1 erysipelas than bacteriological method. The 80% 32% # 7,0% # Sechenov First Moscow State Medical Staphylococci S.aureus-39% University, 2 Infectious Clinical Hospital №2, bacteriological method showed low efficacy in 74.5% MSSA:MRSA = 9:2 PCR results: 3Central Research Institute of Epidemiology, detecting of Str.pyogenes, however, positive S.epidermidis and/or Moscow, Russian Federation results of bacteriological research can serve as MRSA -2 - - S.saprophyticus-43% MRCoNS - 4 - MRCoNS -5 Erysipelas is a common infection of the skin an objective criterion of therapy correction based MRCoNS-20% MSSA - 7 MSSA -1 MSSA - 2 surface layer, unlike cellulitis and necrotizing on identified microbes.
    [Show full text]
  • Reportable Infectious Disease in Maine Annual Report
    Reportable Infectious Diseases in Maine 2006 Summary Reportable Infectious Diseases in Maine 2006 Summary Editors: Tia Bastian, MPH Amy Robbins, MPH Contributors: Mary Kate Appicelli, MPH Geoff Beckett, PA-C, MPH Leif Deyrup, PhD Alexander G. Dragatsi, MPH Kathleen Gensheimer, MD, MPH Mark Griswold, MSc Suzanne Gunston, RN, MPH Theodore Hensley, RN, MSN Dwane Hubert, MPA Sally Lou Patterson Andrew Pelletier, MD, MPH Anne Redmond Sites, MPH Anthony Yartel, MPH Reportable Infectious Diseases in Maine, 2006 Summary This is the thirteenth consecutive annual report on infectious diseases in Maine published by the Division of Infectious Disease. It is intended to provide an overview of communicable diseases of public health importance in Maine. This report would not be possible without the continued support of our healthcare and public health partners throughout the state. They have expended considerable time handling infectious diseases that impact Maine residents. Their active and critical role in the infectious disease surveillance cycle translates into statewide policies and programs that protect our residents from infectious disease through health promotion, disease prevention, and early detection, containment, and treatment. We encourage our partners’ continued support and vigilance in our efforts to protect the people of Maine through timely, complete, and accurate infectious disease reporting. The better we are able to prevent and control disease now, the better positioned we will be to respond to emerging infectious disease threats in the future. For more information on what, when, and how to report infectious disease please see Appendix C (Notifiable Conditions List) of this report, visit our website at www.mainepublichealth.gov, or call 1-800-821-5821.
    [Show full text]
  • Bacterial Skin Infections
    What is Impetigo? • When treated appropriately, impetigo heals over a • Avoid touching the infected areas and prevent others • Impetigo is a superficial bacterial infection of the few days without leaving scars, although there may from touching them too. skin. be temporary redness and darker pigmentation that • Wash hands after touching affected area. • The most common bacteria causing impetigo is may take weeks or months to resolve. • Wash hands before and after applying creams or Staphylococcus aureus, or “Staph aureus”. Less ointments to the affected area. commonly, it can be caused by another bacteria, How is impetigo diagnosed? • Do not share towels or personal items until the Streptococcus. • Impetigo is diagnosed by the typical appearance and infected area is completely healed. Bacterial Skin • Impetigo is common in young children but can symptoms. • Do not let your child return to school or childcare also affect people of other ages, especially those • A skin swab from the affected area may be taken to facilities until the lesions are dried and healed. Infections with skin that is damaged by cuts, insect bites, or identify the bacteria. eczema. • If the infection recurs, a swab from your child’s nose What is erysipelas/cellulitis? • The bacteria can spread by skin-to-skin contact or by to test for the presence of “Staph aureus” may be • Erysipelas and cellulitis are bacterial infections touching contaminated surfaces such as towels and indicated. affecting deeper layers of skin. clothes. • The most common bacteria causing erysipelas or How is impetigo treated? cellulitis is Streptococcus, but other bacteria may be Treatment depends on the severity and extent of the involved, including Staphylococcus aureus.
    [Show full text]